Changeflow GovPing Trade & Sanctions NSF EBBS Program Funds Biological and Biomedica...
Routine Notice Added Final

NSF EBBS Program Funds Biological and Biomedical Engineering Research

Favicon for www.nsf.gov NSF Funding Opportunities
Published
Detected
Email

Summary

The NSF Engineering Biological and Biomedical Systems (EBBS) program funds fundamental research to advance understanding of biological and physiological systems and improve human health. The program supports studies of microbial populations, therapeutic cells and tissues, biosensing platforms, optical imaging and modulation strategies, tissue engineering, and rehabilitation engineering. EBBS research must enable improved biological processes, create novel biomedical technologies, or achieve new understanding of physiological or pathological processes. The program does not support proposals focused on drug design, drug delivery, animal models of disease, therapy validation, or clinical trials. Full proposals are accepted on an ongoing basis.

Published by NSF on nsf.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors NSF Funding Opportunities for new trade & sanctions regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.

What changed

The NSF Engineering Biological and Biomedical Systems (EBBS) program is a funding mechanism for fundamental research in biological and biomedical engineering. The program focuses on mechanistic understanding combined with experimental and computational techniques to develop platforms, devices, organisms, tissues, and processes that advance control of biological functions. Key supported areas include studies of mechanisms driving microbial populations and cells, creation of novel biosensing platforms, optical imaging and modulation strategies, tissue changes or injury research, and rehabilitation engineering. The program explicitly excludes drug design, drug delivery, animal disease model development, therapy testing/validation, and clinical trials.

For researchers and firms in biotechnology, pharmaceutical, and medical device sectors, this funding program may support novel technology development aligned with EBBS priorities. Firms developing biosensing platforms, imaging technologies, tissue engineering solutions, or rehabilitation devices may find this funding relevant. Commercialization-focused projects are directed to NSF's Directorate for Technology, Innovation, and Partnerships (TIP) instead.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.


Synopsis

The Engineering Biological and Biomedical Systems (EBBS) program expand s our understanding of biological and physiological systems, and it helps improve human health. For U.S. leadership in biotechnology, the engineering of biology is required at every scale. E ngineering is needed for sensing biomarkers to making proteins to restoring function s of the body. In EBBS, fundamental mechanistic insight s are combine d with experimental and computational techniques. This approach help s develop platforms, devices, organisms, tissues, and processes that bring new understanding and control of biological function s.

EBBS supports studies of mechanisms that driv e the behavior of microbial populations and cells, and of therapeutic cells and tissues. This includes discovering the underlying engineering principles that are needed to captur e the responses of biological systems and bioreactors. It also includes the creation of novel bio sensing platforms and new optical imaging and modulation strategies. Research that enables the design of biological systems to sense and respond to novel stimuli is welcome. Similarly, projects leading to insight into tissue changes or injury, and to systems that imitate or restore the function s of tissues or organs are encouraged.

P rojects that advanc e rehabilitation engineering through new theories and approaches are supported by the EBBS program. Fundamental engineering research driven by the needs of persons with disabilities is encouraged.

The EBBS program expand s what is possible in biomanufacturing; research may advance biotechnology and /or health. EBBS research must enabl e improved biological processes, create novel biomedical technologies, or achieve new understanding of physiological or pathological processes.

EBBS does not support proposals with a main goal of drug design, drug delivery, or t he development of animal models of disease. Using existing models for experimental testing and validation is acceptable. Projects that focus on testing and validating therapies are not supported. Clinical trials are not supported. L imited studies involving human volunteers may be supported if appropriate to the project objectives. Projects focused on commercialization are more appropriate for the NSF Directorate for Technology, Innovation, and Partnerships (TIP).

Partnerships: To speed discovery and innovation, NSF partners with federal agencies, industry, international groups, and others. Current opportunities are at NSF ENG Partnerships.


Program contacts

Name Email
EBBS Program Team cbet-ebbs@nsf.gov

Awards made through this program

Browse projects funded by this program


Map of recent awards made through this program


Organization(s)

Upcoming due dates

Full proposal accepted anytime

Program guidelines

Apply to PD 26-369Y as follows:

Full proposals submitted via Research.gov: NSF Proposal & Award Policies & Procedures Guide proposal preparation guidelines apply.

Full proposals submitted via Grants.gov: NSF Grants.gov Application Guide guidelines apply. See Grants.gov Proposal Processing in Research.gov for more information.

Share

Published:

April 24, 2026

Get daily alerts for NSF Funding Opportunities

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NSF.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NSF
Published
April 24th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Research institutions Manufacturers Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Scientific research funding Grant program administration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals Medical Devices Scientific Research

Get alerts for this source

We'll email you when NSF Funding Opportunities publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!